<DOC>
	<DOC>NCT02744378</DOC>
	<brief_summary>This clinical study is carried out to assess the efficacy of Tacrolimus and Clobetasol in symptomatic Oral Lichen Planus.</brief_summary>
	<brief_title>Comparison of Tacrolimus 0.1% and Clobetasol 0.05% in the Management of Symptomatic Oral Lichen Planus</brief_title>
	<detailed_description />
	<mesh_term>Lichen Planus, Oral</mesh_term>
	<mesh_term>Lichen Planus</mesh_term>
	<mesh_term>Tacrolimus</mesh_term>
	<mesh_term>Clobetasol</mesh_term>
	<criteria>Clinically and Histologically proven Oral Lichen Planus Symptomatic topical/ systemic medication for OLP in the previous three months contraindication for medications use such as a history of allergy to either corticosteroids/ tacrolimus immunosuppression, or pregnant / lactating females lichenoid reactions either drug induced or due to dental amalgam diabetes mellitus and on oral hypoglycemic drugs systemic involvement such as concurrent skin/genital lesions</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>